PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.




PMID- 28514611
OWN - NLM
STAT- MEDLINE
DA  - 20170517
DCOM- 20170519
LR  - 20170519
IS  - 1533-4406 (Electronic)
IS  - 0028-4793 (Linking)
VI  - 376
IP  - 20
DP  - 2017 May 18
TI  - Osimertinib in EGFR T790M-Positive Lung Cancer.
PG  - 1993
LID - 10.1056/NEJMc1703339 [doi]
FAU - Yin, Yue
AU  - Yin Y
AD  - Shaanxi Provincial Tumor Hospital, Xi'an, China [email protected]
FAU - Li, Jun
AU  - Li J
AD  - Shaanxi Provincial Tumor Hospital, Xi'an, China [email protected]
LA  - eng
PT  - Letter
PT  - Comment
PL  - United States
TA  - N Engl J Med
JT  - The New England journal of medicine
JID - 0255562
SB  - AIM
SB  - IM
CON - N Engl J Med. 2017 Feb 16;376(7):629-640. PMID: 27959700
CIN - N Engl J Med. 2017 May 18;376(20):1992-1994. PMID: 28514610
MH  - Humans
MH  - *Lung Neoplasms
EDAT- 2017/05/18 06:00
MHDA- 2017/05/20 06:00
CRDT- 2017/05/18 06:00
AID - 10.1056/NEJMc1703339#SA2 [pii]
PST - ppublish
SO  - N Engl J Med. 2017 May 18;376(20):1993. doi: 10.1056/NEJMc1703339.

<?xml version="1.0" encoding="UTF-8"?>
<b:Sources SelectedStyle="" xmlns:b="http://schemas.openxmlformats.org/officeDocument/2006/bibliography"  xmlns="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" >
</b:Sources>